Samples Catalogue

At INNODIA, we are committed to advancing research and innovation in Type 1 Diabetes (T1D) by providing access to a diverse collection of biological samples.

Our mission is to accelerate scientific breakthroughs by providing access to high-quality samples for researchers, innovators, and stakeholders worldwide. Whether you’re working on groundbreaking treatments or pioneering new diagnostic tools, our curated collection is here to support your journey.

At this moment we are only hosting the samples corresponding to the Natural History dataset from the previous INNODIA IMI project. 

Natural History Samples Catalogue

Definitions: 

ND:  Newly Diagnosed Participants. All ND participants had a baseline assessment within 6 weeks from diagnosis of T1D (based on the ADA criteria, defined as the time at which insulin therapy was started).

Following up visit schedule for ND participants:

  • ND Visit 1 : Baseline visit (< 6 weeks from diagnosis)
  • ND Visit 2: 3 months follow up
  • ND Visit 3: 6 months follow up
  • ND Visit 4: 9 months follow up
  • ND Visit 5: 12 months follow-up

UFM: Unaffected family members. Participants who have a first-degree relative with T1D (ND participant) and being tested positive for Islet autoantibodies (IAb+). The UFM DNA samples correspond to UFMs who were screened, including not only IAb+ but also those who did not.

Following up visit schedule for UFM participants

  • UFM Visit 1: Baseline/Screening visit (baseline: visit within 3 months following receipt of their autoantibody test result)
  • UFM Visit 2: 6 months follow up
  • UFM Visit 3: 12 months follow up
  • UFM Visit 4: 18 months follow up
  • UFM Visit 5: 24 months follow up
  • UFM Visit 6: 36 months follow up
  • UFM Visit 7: 48 months follow up

Samples (with at least one aliquot) available per visit and sample type:

  • ND Visit 1: 331 serum (FluidX, 0.5 ml/aliquot), 267 EDTA plasma (FluidX, 0.2 ml/aliquot), 602 DNA (FluidX, EDTA plasma, 0.5 ml/aliquot), 501 Urine (FluidX, 1 ml/aliquot), 269 Whole Blood (PAXGENE, 10 ml/aliquot), 325 Stool (Omnigene-GUT, 10 ml/aliquot).

  • ND Visit 2: 499 serum (FluidX, 0.5 ml/aliquot) , 0 EDTA plasma (FluidX, 0.2 ml/aliquot), 0 DNA (FluidX, EDTA plasma, 0.5 ml/aliquot), 475 Urine (FluidX, 1 ml/aliquot), 0 Whole Blood (PAXGENE, 10 ml/aliquot), 332 Stool (Omnigene-GUT, 10 ml/aliquot).

  • ND Visit 3: 448 serum (FluidX, 0.5 ml/aliquot), 0 EDTA plasma (FluidX, 0.2 ml/aliquot), 0 DNA (FluidX, EDTA plasma, 0.5 ml/aliquot), 435 Urine (FluidX, 1 ml/aliquot), 0 Whole Blood (PAXGENE, 10 ml/aliquot), 293 Stool (Omnigene-GUT, 10 ml/aliquot).

  • ND Visit 4: 243 serum (FluidX, 0.5 ml/aliquot), 152 EDTA plasma (FluidX, 0.2 ml/aliquot), 0 DNA (FluidX, EDTA plasma, 0.5 ml/aliquot), 377 Urine (FluidX, 1 ml/aliquot), 170 Whole Blood (PAXGENE, 10 ml/aliquot), 229 Stool (Omnigene-GUT, 10 ml/aliquot).

  • ND Visit 5: 215 serum (FluidX, 0.5 ml/aliquot), 108 EDTA plasma (FluidX, 0.2 ml/aliquot), 0 DNA (FluidX, EDTA plasma, 0.5 ml/aliquot), 278 Urine (FluidX, 1 ml/aliquot), 259 Whole Blood (PAXGENE, 10 ml/aliquot), 119 Stool (Omnigene-GUT, 10 ml/aliquot).

  • UFM Visit 1: 198 serum (FluidX, 0.5 ml/aliquot), 116 EDTA plasma (FluidX, 0.2 ml/aliquot), 4701 DNA (FluidX, EDTA plasma, 0.5 ml/aliquot), 281 Urine (1 ml/aliquot), 191 Whole Blood (PAXGENE, 10 ml/aliquot), 53 Stool (Omnigene-GUT, 10 ml/aliquot).

  • UFM Visit 2: 227 serum (FluidX, 0.5 ml/aliquot), 0 EDTA plasma (FluidX, 0.2 ml/aliquot), 0 DNA (FluidX, EDTA plasma, 0.5 ml/aliquot), 0 Urine (FluidX, 1 ml/aliquot), 0 Whole Blood (PAXGENE, 10 ml/aliquot), 73 Stool (Omnigene-GUT, 10 ml/aliquot).

  • UFM Visit 3: 119 serum (FluidX, 0.5 ml/aliquot), 83 EDTA plasma (FluidX, 0.2 ml/aliquot), 0 DNA (FluidX, EDTA plasma, 0.5 ml/aliquot), 190 Urine (FluidX, 1 ml/aliquot), 112 Whole Blood (PAXGENE, 10 ml/aliquot), 53 Stool (Omnigene-GUT, 10 ml/aliquot).

  • UFM Visit 4: 147 serum (FluidX, 0.5 ml/aliquot), 0 EDTA plasma (FluidX, 0.2 ml/aliquot), 0 DNA (FluidX, EDTA plasma, 0.5 ml/aliquot), 0 Urine (FluidX, 1 ml/aliquot), 0 Whole Blood (PAXGENE, 10 ml/aliquot), 37 Stool (Omnigene-GUT, 10 ml/aliquot).

  • UFM Visit 5: 89 serum (FluidX, 0.5 ml/aliquot), 47 EDTA plasma (FluidX, 0.2 ml/aliquot), 0 DNA (FluidX, EDTA plasma, 0.5 ml/aliquot), 111 Urine (FluidX, 1 ml/aliquot), 80 Whole Blood (PAXGENE, 10 ml/aliquot), 41 Stool (Omnigene-GUT, 10 ml/aliquot).

  • UFM Visit 6: 54 serum (FluidX, 0.5 ml/aliquot), 23 EDTA plasma (FluidX, 0.2 ml/aliquot), 0 DNA (FluidX, EDTA plasma, 0.5 ml/aliquot), 65 Urine (FluidX, 1 ml/aliquot), 62 Whole Blood (PAXGENE, 10 ml/aliquot), 41 Stool (Omnigene-GUT, 10 ml/aliquot).

  • UFM Visit 7: 30 serum (FluidX, 0.5 ml/aliquot), 11 EDTA plasma (FluidX, 0.2 ml/aliquot), 0 DNA (FluidX, EDTA plasma, 0.5 ml/aliquot), 33 Urine (FluidX, 1 ml/aliquot), 33 Whole Blood (PAXGENE, 10 ml/aliquot), 25 Stool (Omnigene-GUT, 10 ml/aliquot).